Visual disorders associated with omeprazole and their relation to CYP2C19 polymorphism

Pharmacogenetics

Volumn 12, Issue 1, 2002, Pages 73-75

  Lutz, Markus ^a   Schwab, Matthias ^a   Griese, Ernst Ulrich ^a   Marx, Claudia ^a   Müller Oerlinghausen, Bruno ^a   Schönhöfer, Peter S ^a   Meisner, Christoph ^a   Gleiter, Christoph H ^a   Eichelbaum, Michel ^a   Mörike, Klaus ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2C19; OMEPRAZOLE;

ADULT; AGED; ARTICLE; DIPLOPIA; DRUG METABOLISM; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HEMIANOPIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCOTOMA; VISUAL DISORDER;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ANTI-ULCER AGENTS; ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INHIBITORS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MIXED FUNCTION OXYGENASES; OMEPRAZOLE; PHENOTYPE; POLYMORPHISM, GENETIC; PROTON PUMPS; RETROSPECTIVE STUDIES; VISION DISORDERS;

EID: 18244363391     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-200201000-00010     Document Type: Article

References (11)

1. Ocular damage associated with proton pump inhibitors
2. Omeprazole and ocular damage
3. Pharmacogenetics and adverse drug reactions
4. Identification of human liver cytochrome P450 isoforms mediating secondary omeprazole metabolism
5. Interphenotype differences in disposition and effect on gastrin levels of omeprazole - Suitability of omeprazole as a probe for CYP2C19
6. Detection of CYP2C19 alleles *1, *2 and *3 by multiplex polymerase chain reaction
7. Allelic, genotypic and phenotypic distributions of S-mephenytoin 4′-hydroxylase (CYP2C19) in healthy Caucasian populations of European descent throughout the world
8. Antidepressants
9. Different contributions of cytochrome P450 C29 and 3A4 in the oxidation of omeprazole by human liver microsomes: Effects of contents of these two forms in individual human samples
10. Nonlinear kinetics after high-dose omeprazole caused by saturation of genetically variable CYP2C19